Merck & Co. Strengthens its HIV Pipeline with Two Licensing Deals

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 7 (Table of Contents)

Published: 30 Jul-2012

DOI: 10.3833/pdr.v2012.i7.1785     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

In its first major deal, Chimerix has granted Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details